It is a business services private limited company based in Aurangabad, Maharashtra, India, established in 2016.
2016 | Aurangabad, Maharashtra, India | ActiveRextor Pharmaceuticals Private Limited, a active private limited company, was established on 19 September 2016 in Aurangabad, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2016PTC285997. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Dipak Ishwar Bainade (Director), Rohidas Sahebarav Ambhore (Director), Narayan Ishwarsingh Bainade (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at C/O Agaji Kisan Autade, Pap-08, Shendra Midc, Aurangabad, Maharashtra, 431001.
U74999MH2016PTC285997
285997
19 September 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rextor Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dipak Ishwar Bainade | Director | 01 Jan 2024 | Current |
| Rohidas Sahebarav Ambhore | Director | 19 Sep 2016 | Current |
| Narayan Ishwarsingh Bainade | Director | 19 Sep 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rextor Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.48% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
Unlock access to Rextor Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rextor Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rextor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rextor Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dipak Ishwar Bainade was appointed as a Director was appointed as a Director on 01 Jan 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
Progress on Rextor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Rextor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.
Rohidas Sahebarav Ambhore was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 9 years 2 months . was recorded as a recent event.
The activity Narayan Ishwarsingh Bainade was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 9 years 2 months . was completed.
Rextor Pharmaceuticals Private Limited was registered on 19 Sep 2016 with Roc Mumbai & aged 9 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Rextor Pharmaceuticals Private Limited is U74999MH2016PTC285997.
Rextor Pharmaceuticals Private Limited is headquartered at C/O Agaji Kisan Autade, Pap-08, Shendra Midc, Aurangabad, Maharashtra, 431001.
Rextor Pharmaceuticals Private Limited was incorporated on 19 September 2016.
The current directors of Rextor Pharmaceuticals Private Limited are
The primary industry of Rextor Pharmaceuticals Private Limited is Business Services.
Rextor Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rextor Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rextor Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX